Sanos Group
Jakob Brix Christensen is a seasoned finance professional with extensive experience in the biotech, pharmaceutical, and medical industries. Jakob Brix has held leadership roles in companies such as Unibio, BioPorto A/S, Novozymes, and ORIGIO, where Jakob Brix managed finance, investor relations, and business development. Jakob Brix has also worked as a financial advisor in mergers and acquisitions at Handelsbanken Capital Markets. Jakob holds a Master's degree in Economics and Business Administration and has completed additional education in leadership and finance.
Sanos Group
Sanos Group is a Full Circle Clinical Research & Development Organization encompassing five independent business units: NBCD, Sanos Clinic, Sanos Supply, Studies&Me and Blueskin. Every division within the Sanos Group is committed to delivering top-tier clinical research, constantly enhancing our approach to pioneering innovative clinical trials for both clients and patients.